Skip to main content
logo
Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
5.96
-0.23 (-3.72%)
At close: Sep 9, 2026, 4:00 PM EDT
5.88
-0.08 (-1.34%)
After-hours: Sep 9, 2026, 5:15 PM EDT

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
Developing Treatments for Inflammatory Diseases
2.85M2.37M2.38M1.21M
Total
2.85M2.37M2.38M1.21M

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
United States
2.85M2.37M2.38M1.21M
Total
2.85M2.37M2.38M1.21M